Categories
-
Adhesives
6
Amines
101
Amino Acids
185
Analytical Reagents
714
Antibiotics
255
Bioactive Small Molecules
742
Aroma Chemicals
213
Biochemicals
1051
Boronic Acids
4
Buffers
98
Building Blocks
1928
Carbohydrates
180
Catalysts
111
Chiral Compounds
59
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
262
Flavours and Fragrance Materials
214
Fluorinated Products
51
Furans
6
Gases in Solution
49
Grignard Reagents
26
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
345
Ion-Pair Reagents
24
Ligands
80
Organics
1440
Oxazoles
3
Peptide Reagents
91
Phenols
50
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
57
Pyrimidines
31
Quaternary Ammonium salts
43
Reagents
108
Research Organics & Inorganics
804
Salts
299
Sealing Compounds
1
Sherclin
1
Solvents
127
Stains & Indicators
305
Sugars
64
Tailor-made solutions
1
Testing Standards
4
Uncategorised
30
Water Analysis
13
beta-Nicotinamide adenine dinucleotide phosphate disodium salt
(42474095 | 24292-60-2)
CAS: | 24292-60-2 |
---|---|
Molecular Formula: | C21H26N7Na2O17P3 |
Molecular Weight: | 787.37 |
Availablility: | In Stock |
---|---|
Downloads: | | |
42474095-1g | 1g | £62.10 | |
Bulk Order |
42474095-1g | 1g | €87.00 | |
Bulk Order |
42474095-1g | 1g | $93.20 | |
Bulk Order |
Safety Data Sheet
Certificate of Analysis
Product Detail
Product Code | 42474095 | ||||
Product Name | beta-Nicotinamide adenine dinucleotide phosphate disodium salt | ||||
Categories | Biochemicals | ||||
CAS | 24292-60-2 | ||||
Molecular Formula | C21H26N7Na2O17P3 | ||||
Molecular Weight | 787.37 | ||||
Storage Details | -15 to -20 °C | ||||
Harmonised Tariff Code | 29349990 |
Product Specification
Solubility | 200 mg/ml in water | ||||
Appearance | White to yellow powder | ||||
A250/A260 | 0.83 ± 0.03 | ||||
A280/A260 | 0.21 ± 0.02 | ||||
A340/A260 | 0.43 ± 0.02 | ||||
Water Content ( Karl Fisher) | ≤8% | ||||
NADP (HPLC Purity) | ≥93% | ||||
NADP content | ≥90% |
Safety Information
Pictograms |
|
||||
Signal word | none | ||||
Hazard statements |
|
||||
Precautionary statements |
|